UNC13D Antikörper (Internal Region)
Kurzübersicht für UNC13D Antikörper (Internal Region) (ABIN374716)
Target
Alle UNC13D Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Internal Region
-
Spezifität
- This antibody reacts to Munc13-4 / UNC13D.
-
Kreuzreaktivität (Details)
-
Species reactivity (expected):Mouse, Rat, Canine.
Species reactivity (tested):Human. -
Aufreinigung
- Affinity chromatography
-
Immunogen
- Peptide with sequence C-ETQKHKKDLHPLFD, from the internal region of the protein sequence
-
-
-
-
Applikationshinweise
-
ELISA: 1/128000. Western Blot: 1 - 3 μg/mL. Immunohistochemistry on paraffin sections: 2.5 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- UNC13D (Unc-13 Homolog D (UNC13D))
-
Andere Bezeichnung
- UNC13D
-
Hintergrund
- Secretion of the contents of cytolytic granules at the immunologic synapse is a highly regulated process essential for lymphocyte cytotoxicity. This process requires the rapid transfer of perforin containing lytic granules to the target cell interface, followed by their docking and fusion with the plasma membrane. Munc 13-4 localises with cytotoxic granules at the immunologic synapse. Munc 13-4 is essential for the priming step of cytolytic granule secretion preceding vesicle membrane fusion. There are two named isoforms.Synonyms: Munc13-4, Protein unc-13 homolog D
-
Gen-ID
- 201294, 9606
-
UniProt
- Q70J99
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-